Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
published : Previous years source : Www.fda.gov save search
FDA Roundup: March 26, 2024
Published: 2024-03-26 (Crawled : 20:00) - fda.gov
IMGN | $31.23 0.03% 49M
|
Health Technology
| Email alert
Add to watchlist
fda
FDA Roundup: March 1, 2024
Published: 2024-03-01 (Crawled : 21:00) - fda.gov
BSX | $67.44 -0.93% 0.0% 6.5M
|
Health Technology
| Email alert
Add to watchlist
fda
FDA Roundup: February 23, 2024
Published: 2024-02-23 (Crawled : 23:00) - fda.gov
FNCTF | $11.128 -20.84% 580
|
Communications
| Email alert
Add to watchlist
fda
FDA Roundup: December 5, 2023
Published: 2023-12-05 (Crawled : 14:30) - fda.gov
LLY | $750.77 -0.12% 0.0% 2.3M
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
fda
FDA Roundup: November 14, 2023
Published: 2023-11-14 (Crawled : 21:00) - fda.gov
BDX | $234.72 -0.19% 0.0% 830K
|
Health Technology
|
| O: -0.14%
H: 0.97%
C: 0.32%
AMZN 4 | $183.63 -1.34% -1.36% 48M
|
Retail Trade
|
| O: 0.86%
H: 0.16%
C: -2.62%
fda
FDA Roundup: November 7, 2023
Published: 2023-11-07 (Crawled : 21:00) - fda.gov
TNDM | $31.86 -4.9% -5.15% 1.1M
|
Health Technology
|
| O: -0.06%
H: 0.65%
C: -4.49%
fda
FDA Raises Concerns About Probiotic Products Sold for Use in Hospitalized Preterm Infants
Published: 2023-10-26 (Crawled : 15:30) - fda.gov
ABT | $108.89 -0.2% 0.04% 4.6M
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
fda
FDA Approves New Therapy for Rare Form of Blood Cancers Called Myelodysplastic Syndromes
Published: 2023-10-24 (Crawled : 20:00) - fda.gov
ABT | $108.89 -0.2% 0.04% 4.6M
|
Health Technology
|
| O: -0.89%
H: 0.09%
C: -1.04%
fda rare blood therapy
FDA Roundup: October 17, 2023
Published: 2023-10-17 (Crawled : 21:00) - fda.gov
BMY | $48.51 0.48% 0.0% 12M
|
Health Technology
|
| O: 0.05%
H: 0.33%
C: -0.96%
fda
FDA Issues Warning Letters to Firms Marketing Unapproved Eye Products
Published: 2023-09-12 (Crawled : 15:30) - fda.gov
WBA | $17.655 -1.09% -1.1% 10M
|
Retail Trade
|
| O: 0.51%
H: 3.39%
C: 0.84%
fda eye
FDA Roundup: August 15, 2023
Published: 2023-08-15 (Crawled : 20:00) - fda.gov
FNCTF | $11.128 -20.84% 580
|
Communications
|
| O: 1.51%
H: 0.0%
C: -1.03%
PFE A | $25.91 0.19% -0.04% 34M
|
Health Technology
|
| O: -0.71%
H: 1.45%
C: 0.97%
fda
La FDA aprueba el primer tratamiento oral para la depresión posparto
Published: 2023-08-08 (Crawled : 14:00) - fda.gov
SAGE | $15.33 -0.71% -0.72% 850K
|
Health Technology
|
| O: -12.79%
H: 14.24%
C: 13.35%
fda
FDA Approves First Oral Treatment for Postpartum Depression
Published: 2023-08-04 (Crawled : 23:00) - fda.gov
SAGE | $15.33 -0.71% -0.72% 850K
|
Health Technology
| Email alert
Add to watchlist
fda depression treatment
FDA Roundup: July 21, 2023
Published: 2023-07-21 (Crawled : 20:00) - fda.gov
JNJ | $147.59 0.05% 0.0% 8.5M
|
Health Technology
| Email alert
Add to watchlist
fda
FDA Approves First Nonprescription Daily Oral Contraceptive
Published: 2023-07-13 (Crawled : 13:00) - fda.gov
PRGO A | $30.13 -0.63% 0.0% 1.7M
|
Health Technology
|
| O: 5.77%
H: 0.0%
C: -5.0%
fda contraceptive
FDA Approves First Gene Therapy for Adults with Severe Hemophilia A
Published: 2023-06-29 (Crawled : 22:00) - fda.gov
BMRN S | $91.51 -0.77% -0.78% 1.9M
|
Health Technology
|
| O: 1.2%
H: 1.97%
C: -3.69%
fda therapy
FDA Approves First Gene Therapy for Treatment of Certain Patients with Duchenne Muscular Dystrophy
Published: 2023-06-22 (Crawled : 18:00) - fda.gov
SRPT | $118.385 -3.65% -3.79% 770K
|
Health Technology
|
| O: -3.2%
H: 0.03%
C: -4.89%
fda treatment duchenne therapy
FDA Permits Marketing of First COVID-19 At-Home Test Using Traditional Premarket Review Process
Published: 2023-06-06 (Crawled : 19:00) - fda.gov
HLTH | $0.153 -5.9% -6.27% 510K
|
|
| O: -0.96%
H: 0.15%
C: -9.39%
covid-19 fda test review
FDA Roundup: March 21, 2023
Published: 2023-03-21 (Crawled : 20:00) - fda.gov
INSP | $223.14 -3.71% 0.0% 270K
|
Health Technology
|
| O: -0.69%
H: 1.23%
C: -1.98%
fda
FDA Roundup: September 23, 2022
Published: 2022-09-23 (Crawled : 20:00) - fda.gov
LLY | $750.77 -0.12% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
fda
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M
|
Wholesale Trade
PXMD | $0.7375 79.09% 44.16% 4.5M
|
Health Technology
DYNT | $0.371 -5.12% 43.09% 3.3M
|
Health Technology
LGVN P 3 d | $2.94 73.96% 42.52% 57M
|
HUBC | $1.94 49.23% 32.99% 73M
|
n/a
SPCB | $0.4044 46.52% 31.75% 130M
|
Electronic Technology
ONVO | $1.34 32.66% 24.62% 54M
|
Health Technology
OMQS | $0.6869 32.1% 24.3% 3.6M
|
Professional, Scientific, and T...
SNPO | $10.555 29.67% 22.88% 4M
|
AMBI | $3.72 -26.77% 21.77% 9.8K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.